1995•Birkhäuser Basel eBooksRequires access

Molecular Mechanisms of Anti-Asthma Therapy

Peter John Barnes

Open publisher page 9 citations

Abstract

Asthma is one of the commonest chronic disease world-wide and anti-asthma medications are widely prescribed. Asthma is a complex chronic inflammatory disease, involving many cells, mediators and inflammatory responses. Current anti-asthma therapy is categorized as bronchodilator (β 2 -agonists, theophylline, anticholinergics) or anti-inflammatory (glucocorticosteroids, cromones, immunomodulators), although the distinction is not always clear-cut. Bronchodilators are believed to act predominately by relaxing airway smooth muscle, whereas anti-inflammatory drugs suppress the inflammatory response in asthmatic airways. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

About this research paper

What this paper is about

Asthma is one of the commonest chronic disease world-wide and anti-asthma medications are widely prescribed. Asthma is a complex chronic inflammatory disease, involving many cells, mediators and inflammatory responses. Current anti-asthma therapy is categorized as bronchodilator (β 2 -agonists, theophylline, anticholinergics) or anti-inflammatory (glucocorticosteroids, cromones, immunomodulators), although the distinction is not always clear-cut. Bronchodilators are believed to act predominately by relaxing airway smooth muscle, whereas anti-inflammatory drugs suppress the inflammatory response in asthmatic airways. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Asthma is one of the commonest chronic disease world-wide and anti-asthma medications are widely prescribed. Asthma is a complex chronic inflammatory disease, involving many cells, mediators and inflammatory responses. Current anti-asthma therapy is categorized as bronchodilator (β 2 -agonists, theophylline, anticholinergics) or anti-inflammatory (glucocorticosteroids, cromones, immunomodulators), although the distinction is not always clear-cut. Bronchodilators are believed to act predominately by relaxing airway smooth muscle, whereas anti-inflammatory drugs suppress the inflammatory response in asthmatic airways. These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Key concepts: Asthma, Theophylline, Medicine, Bronchodilator, Disease, Bronchodilator Agents, B2 receptor, β2 adrenergic receptor

Related papers

Back to paper searchBrowse research topicsOriginal source
Molecular Mechanisms of Anti-Asthma Therapy — Research Paper | ScholarLens